Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Increase in Institutional deliveries under Janani Suraksha Yojana: Ashwini Kumar Choubey
Keeping in view the importance of institutional deliveries, several initiatives have been taken by the Ministry of Health and…
Expert panel to submit report soon on priority individual for COVID vaccine
An expert committee set up to develop the criteria for identifying significant comorbidities present in a person, which would make…
Overall COVID-19 seropositivity among healthcare workers over 25 per cent: Ashwini Choubey
The overall COVID-19 seropositivity among healthcare workers is assessed to be 25.7 per cent as per the third seroprevalence…
Godrej & Boyce aims to strengthen Vaccine Cold Chain till the last mile
Godrej & Boyce, the flagship company of the Godrej Group, has been contributing to making India self-reliant since its…
University of Otago introduces DIVA, Clinical Auditing computer software to healthcare
University of Otago-designed computer software for helping surgeons monitor how their patients are doing during their time in…
- Advertisement -
BD India launches PortShala, medical education programme for healthcare professionals
Some chemotherapy medications can only be given through a port as some patients have veins that are very difficult to access
International Harmonising of the standards and specifications will boost the Medical devices…
In the next decade India should be a medical devices hub and to make that possible, the government is focusing on the Harmonising…
IHH Healthcare reiterates commitment to Fortis Healthcare, awaits direction from Supreme Court
IHH Healthcare ( Group) has reiterated its commitment to India, announcing its intent to continue on its growth plans for Fortis…
Medall makes pre-natal testing accessible & affordable for pregnant women
Medall has announced a comprehensive Pregnancy Care package including all essential pre-natal blood tests and scans for the three…
AstraZeneca’s Dapagliflozin gets marketing authorisation for chronic kidney disease in India
AstraZeneca India has received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for the treatment of…